Check-Cap (MBAI) Notes Payables (2024 - 2025)
Check-Cap (MBAI) posted Notes Payables of $416000.0 for Q4 2025, up 127.07% sequentially from $183202.0 in Q4 2024, and up 127.07% YoY from $183202.0 in Q4 2024.
Check-Cap (MBAI) Notes Payables (2024 - 2025) Analysis & Trends
Check-Cap has reported Notes Payables for 2 years, with the latest figure at $416000.0 in Q4 2025.
- Quarterly Notes Payables rose 127.07% year-over-year to $416000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $416000.0 (up 127.07% YoY) and the FY2025 annual result came in at $416000.0, up 127.07% from the prior year.
- Notes Payables climbed to $416000.0 in Q4 2025 per MBAI's latest filing, from $183202.0 in the prior quarter.
- Over five years, Notes Payables peaked at $416000.0 in Q4 2025 and troughed at $183202.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Check-Cap | 8.23 Mn | 6.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 416,000.00 |
| Dec 31, 2024 | 183,202.00 |